Home  >  Speakers  >  Dimitrios P. Kontoyiannis
Dimitrios P. Kontoyiannis

Dimitrios P. Kontoyiannis MD, MS, ScD, PhD, FACP, FIDSA, FECMM, FAAM, FAAAS

Deputy Head, Professor | Houston, Texas    United States of America
Infectious Disease, Internal Medicine
Experimental Mycology, Antifungal Pharmacology,...More
Spoken at 4 events

Biography :

Dimitrios P. Kontoyiannis is the Texas 4000 Distinguished Endowed Professor and Deputy Head in the Division of Internal Medicine at MD Anderson Cancer Center in Houston, TX. His research group is credited for sustained and impactful contributions to medical and translational mycology through advances in antifungal pharmacology, the study of host defenses against fungi, novel diagnostics, clinical trials, dedicated mentoring, organizational service and life-saving patient care.

Dr. Kontoyiannis has authored over 540 peer-reviewed manuscripts and has given over 340 lectures in international conferences and institutions in the US and abroad. He is considered a leading mycology expert worldwide with an H index of 98 with over 40850 citations. He is the recipient of many national and international awards and is the past president-elect of Immunocompromised Host Society (2016-2018).

He is a fellow of the American College of Physicians, the Infectious Diseases Society of America, an inaugural fellow of the European Confederation for Medical Mycology, a fellow in the American Academy of Microbiology and a fellow in the American Association for the Advancement of Science (AAAS) He was recently elected as member in class II–Medicine of the European Academy of Sciences and Arts. He leads the MDACC Mycology Research Program that received in 2018 by the Diamond Status of Excellence in Mycology from the European Confederation of Medical Mycology.

***********************
************* ***** ********
 
For speaker's contact information - Contact us

Specialties

Infectious Disease, Internal Medicine

Interested Topics

Experimental Mycology, Antifungal Pharmacology, Immunocompromised Host, Advanced Molecular Cloning, Oncology, Novel Diagnostics, Clinical Trials

State Licenses

This section has yet to be updated by the speaker.

Board Certifications

This section has yet to be updated by the speaker.

Professional Association

This section has yet to be updated by the speaker.

Languages

English

Conference Session Materials

The conference session material has yet to be added by the speaker.

Convert
Onsite to Virtual Conference

Market your online event to Million plus Healthcare professionals.